z-logo
open-access-imgOpen Access
Serum IP-10 profiles over time in treatment-experienced hepatitis C patients treated with a HCV NS3/4A protease inhibitor in combination with peginterferon and ribavirin
Author(s) -
Sven Erik Johansson,
Leen Vijgen,
Talloen Willem,
Maria Beumont–Mauviel,
Peeters Monika,
Oliver Lenz,
Aerssens Jeroen
Publication year - 2013
Publication title -
frontiers in immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.646
H-Index - 124
ISSN - 1664-3224
DOI - 10.3389/conf.fimmu.2013.02.00832
Subject(s) - ribavirin , medicine , gastroenterology , hepatitis c virus , hepatitis c , protease inhibitor (pharmacology) , immunology , virology , viral load , virus , antiretroviral therapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here